<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01914237</url>
  </required_header>
  <id_info>
    <org_study_id>Castor-2012-04</org_study_id>
    <nct_id>NCT01914237</nct_id>
  </id_info>
  <brief_title>A Multi-center Trial of Single-Branched Stent Graft System to Treat Aortic Dissection</brief_title>
  <official_title>A Multi-center Trial of Castor Single-Branched Stent Graft System for Endovascular Repair of Aortic Dissection.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanjing PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim:Castor is a novel single-branched stent graft system for endovascular repair of aortic
      arch dissection. This is a prospective, one-arm, open, multi-center, pre-market study of
      Castor stent to evaluate its efficacy and safety in treatment of aortic dissection.

      Number of patients: 70 patients will be included and undertaken endovascular repair with
      Castor stent.

      Follow-up: 1.aortic computed tomographic angiography (CTA) examination 6 and 12 months after
      the surgery 2.telephone or clinical follow-up 30 days and 2-5 years after the surgery

      Primary Outcome Measure: success rate of endovascular repair for efficacy measurement.

      Secondary Outcome Measure: 1 year stent related adverse event rate for safety measurement.

      Other Outcome Measures:

        1. efficacy:

             -  1 year success rate of treatment

             -  1 year patency rate of branch stent

        2. safety:

             -  in-hospital mortality

             -  complication rate of neural system

             -  1 year dissection or stent related mortality
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success rate of endovascular repair</measure>
    <time_frame>during the surgery</time_frame>
    <description>- during the surgery: successful conduction, accurate positioning and release, and no warping, folding, narrowing or blocking of the stent graft system. Immediately after the stent release, angiography shows both main stent and side arm stent patency, successful exclusion of dissection and no arteriorrhexis or dissection rupture.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>1 year stent related adverse event rate</measure>
    <time_frame>1 year</time_frame>
    <description>unexpected breakage and shifting of the stent
type I or type III endoleak which needs intervention
dissection rupture around the stent</description>
  </secondary_outcome>
  <other_outcome>
    <measure>1 year success rate of treatment</measure>
    <time_frame>1 year</time_frame>
    <description>complete exclusion of the dissection
no dissection rupture
no type I or type III endoleak which needs twice intervention
false lumen of aorta around stent graft closed with thrombus</description>
  </other_outcome>
  <other_outcome>
    <measure>1 year patency rate of branch stent</measure>
    <time_frame>1 year</time_frame>
    <description>The incidence of more than 50% branch stent patency</description>
  </other_outcome>
  <other_outcome>
    <measure>in-hospital mortality</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 1 week</time_frame>
    <description>mortality of patients caused by dissection related postoperative complications before discharge.</description>
  </other_outcome>
  <other_outcome>
    <measure>complication rate of neural system</measure>
    <time_frame>2 years</time_frame>
    <description>complication rate of neural system related to the stent graft</description>
  </other_outcome>
  <other_outcome>
    <measure>1 year dissection or stent related mortality</measure>
    <time_frame>1 year</time_frame>
    <description>1 year dissection or stent related mortality</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Distal Aortic Dissection</condition>
  <arm_group>
    <arm_group_label>Castor Stent Graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To study the safety and efficacy of Castor single-branched stent graft system in endovascular repair of aortic dissection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Castor Stent Graft</intervention_name>
    <description>Endovascular Repair of Aortic Dissection</description>
    <arm_group_label>Castor Stent Graft</arm_group_label>
    <other_name>Castor Single-Branched Stent Graft System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age from 18 to 80, male or unpregnant female

          -  diagnosed as aortic dissection

          -  proximal tear of the dissection locates between 15mm to the distal end of left common
             carotid artery and 20mm to the distal end of left subclavian artery (LSA) or inverse
             tear to LSA

          -  good compliance with the instructions and cooperate with follow-up

          -  voluntarily signed the informed consent form

        Exclusion Criteria:

          -  Pregnant female

          -  no appropriate vessel approaches

          -  patients with connective tissue diseases (such as Marfan syndrome)

          -  allergic to nitinol or contrast medium

          -  bad compliance with the instructions and follow-up

          -  estimated remaining life is less than 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zaiping JING, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Vascular Surgery, Changhai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zaiping JING, MD</last_name>
    <phone>86-21-31166666</phone>
    <email>jingzp@xueguan.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Vascular Surgery, Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zaiping JING, MD</last_name>
      <phone>86-21-31166666</phone>
      <email>jingzp@xueguan.net</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2013</study_first_submitted>
  <study_first_submitted_qc>August 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2013</study_first_posted>
  <last_update_submitted>August 1, 2013</last_update_submitted>
  <last_update_submitted_qc>August 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Zaiping JING</investigator_full_name>
    <investigator_title>Director of Department of Vascular Surgery</investigator_title>
  </responsible_party>
  <keyword>Single-Branched Stent Graft System</keyword>
  <keyword>Aortic Dissection</keyword>
  <keyword>Endovascular Repair</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Castor Oil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

